Acadia Healthcare (NASDAQ:ACHC) Earns Outperform Rating from Royal Bank of Canada

Acadia Healthcare (NASDAQ:ACHCGet Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Royal Bank of Canada in a report released on Friday,Benzinga reports. They presently have a $64.00 price objective on the stock. Royal Bank of Canada’s price objective points to a potential upside of 42.48% from the company’s current price.

ACHC has been the subject of several other reports. KeyCorp upgraded shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective for the company in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Barclays decreased their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. TD Cowen decreased their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Check Out Our Latest Analysis on ACHC

Acadia Healthcare Stock Down 0.4 %

ACHC stock opened at $44.92 on Friday. The firm has a 50 day moving average of $40.54 and a 200 day moving average of $57.96. The stock has a market capitalization of $4.17 billion, a PE ratio of 14.73, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the business earned $0.91 EPS. Sell-side analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently made changes to their positions in the company. GAMMA Investing LLC increased its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in Acadia Healthcare by 3.5% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after acquiring an additional 257 shares in the last quarter. Atria Investments Inc increased its holdings in Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after acquiring an additional 308 shares in the last quarter. KBC Group NV increased its holdings in Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after acquiring an additional 338 shares in the last quarter. Finally, Tidal Investments LLC increased its holdings in Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after acquiring an additional 340 shares in the last quarter.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.